Read the link again. You ask questions that have been answered...

  1. 21,003 Posts.
    lightbulb Created with Sketch. 178
    Read the link again. You ask questions that have been answered in the links. I can lead you to the answers but you have to make some effort or you will never learn.

    I read the link from your unofficial website. It says:

    The ICMR had recommended the use of the anti-malaria drug as a preventive treatment against COVID-19 for asymptomatic healthcare workers in non-COVID hospitals, frontline personnel deployed in containment zones, and paramilitary/police officials involved in coronavirus infection-related activities.

    Here is the official ICMR website. I made the effort to go over it to validate the claim from your unoffical website. It can't be validated.

    https://www.icmr.gov.in/cpapers.html

    So if you can verify it from the official website then fine. I am aware that the claims are false from other efforts I have made.

    I think you need to get a grip and look at the numbers. 230 million people 23,000 deaths.
    Does it actually matter who took it when?


    Even a blind plank of wood knows it does.
    If there were only 116 people who took Ivermectin, how can those numbers you give be even considered as a proper trial?
    If 2000 took Ivermectin, how could it be even considered as a proper trial?
    Soooooo how many people took Ivermectin?

    Again, here is the official government website. Validate the unofficial website by showing where the official website says:

    https://www.icmr.gov.in/index.html


    The ICMR had recommended the use of the anti-malaria drug as a preventive treatment against COVID-19 for asymptomatic healthcare workers in non-COVID hospitals, frontline personnel deployed in containment zones, and paramilitary/police officials involved in coronavirus infection-related activities.

    Did you?
    https://hotcopper.com.au/data/attachments/3596/3596318-56b9cbc9b10b1c412638e40e1baf5e57.jpg


 
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.